Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

Completed · Phase 3 · Has a placebo group

Conditions studied: OSA

In brief

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obstructive Sleep Apnea.

Key facts

Study ID
NCT05811247
Run by
Apnimed
People needed
660
Starts
2023-08-28
Expected to finish
2025-05-07
Last updated by the study team
2025-11-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.